Introduction {#Sec1}
============

Both undersedation and oversedation have an obvious effect on morbidity and mortality in critically ill patients \[[@CR1]\]. The electroencephalographic (EEG) bispectral index (BIS) has been shown to be a quantifiable measure of the hypnotic effect of anesthetic drugs on the central nervous system \[[@CR2]--[@CR4]\]. A correlation between BIS values and the administrated dose of intravenous and inhalational anesthetics has been demonstrated: the progressive deepening of anesthesia induces a corresponding progressive reduction in BIS values \[[@CR5]\]. Doi et al. showed a good correlation between BIS, propofol blood concentration and clinical sedation criteria in patients undergoing minor surgery \[[@CR6]\]. Similar results were obtained in the study of Lee in respect to propofol effect site concentration and BIS values \[[@CR7]\]. Park et al. \[[@CR8]\] observed moderate correlation (Spearman's coefficient *r* = −0.559) between BIS values and predicted plasma concentration of propofol during recovery from propofol anesthesia in children.

In the literature different data exist with respect to the utility of BIS for monitoring prolonged sedation especially in the critically ill or mechanically ventilated patients. Data on BIS monitoring in the intensive care unit (ICU) are controversial. Leslie et al. \[[@CR9]\] noted that BIS decreases linearly as propofol blood concentrations increase in healthy male volunteers. Simmons et al. \[[@CR10]\] studied 62 mechanically ventilated patients and demonstrated good correlation between BIS and the SAS (Sedation--Agitation Scale), however the correlation varied in medical, surgical and trauma patients. Riker et al. \[[@CR11]\] found good correlation between BIS and the SAS although the authors noted that electromyographic interference could affect the accuracy of BIS. Frenzel et al. \[[@CR12]\] examined the correlation between BIS values and different clinical depth of sedation scales (OAAS, modified Ramsay scale, modified Glasgow Coma Scale, Cook Scale, and Sedation-Agitation Scale) in 19 patients who required mechanical ventilation for more than 24 h. The authors noted moderate correlation between BIS and each sedation score in 11 patients and no correlation in 8 patients. They found no parameters distinguishing between these two groups. Riess et al. \[[@CR13]\] noted that although BIS correlates with Ramsay sedation score in critically ill patients, electromyographic activity and the patients' temperature instability increases BIS values.

In critically ill patients, the alterations of pharmacokinetics and a high interpatient variability of the pharmacodynamic effect can be seen. A common complication of sedation is tolerance, which can modify the concentration-effect-relationship \[[@CR14]\]. When a drug in prolonged infusion is administered, circadian rhythms also have to be taken into account as factors influencing both pharmacokinetics and pharmacodynamics. Animal studies have shown that the maximum hypnotic effect of general anesthetics is generally obtained during the rest phase \[[@CR15]\]. Challet et al. \[[@CR16]\] recently demonstrated that the duration of propofol anesthesia in rats exhibits a three-fold amplitude variation, depending on the hour of administration. The longest duration occurred during the natural sleep period (30 vs. 10 min during the activity phase). The authors did not measure blood concentrations in this study. It is possible that their observations resulted partly from circadian fluctuations in pharmacokinetic properties. However, such fluctuations in propofol pharmacodynamics should also be taken into consideration. It has been observed that sedative effect of propofol is mediated by GABA~A~ receptors in an endogenous sleep pathway \[[@CR17]\]. No literature data reflecting propofol chronopharmacokinetics and chronopharmacodynamics in humans exist.

The aim of our study was to propose pharmacokinetic (PK) and pharmacodynamic (PD) models of propofol and to examine the circadian rhythms in propofol concentrations, sedative effects as well as the time-dependent changes in the monitored physiological parameters during prolonged propofol infusion in ICU patients.

Materials and methods {#Sec2}
=====================

Patients {#Sec3}
--------

The study was performed with approval of the local Ethics Committee in 11 ICU patients of both genders. The exclusion criteria were: administration of neuromuscular blockers, head trauma and known neurological disorders that might alter EEG interpretation: metabolic or hypoxic encephalopathy, meningoencephalitis, stroke, tumors and perinatal neurologic disorders. Bispectral Index was measured using an EEG monitor (BIS, Monitor Intelli Vue MP60, Philips). Patients had conventional monitoring with at least electrocardiographic monitoring, arterial blood pressure monitoring, body temperature monitoring, and pulseoximetry. Patients were studied in the absence of stimulation when they were clinically stable. Vasopressors had not been given during the study period.

All the patients were sedated with propofol (Perfusion Space Pump, Braun, Germany) for more than 24 h, and the infusion rate was constant during the study period, except patient 6, who required changes in the infusion rate. Patient 3 was excluded from analysis since no blood samples were collected. The initial propofol dose was 1.5 mg per kg followed by maintenance doses of 0.7--0.9 mg/kg/h. Blood samples for the propofol assay were collected from the patients' artery every hour during the second and third day of infusion and then 3, 5, 10, 15, 30, 60, 120, 180, 240 min after termination of the propofol infusion. The values of BIS, systolic (SBP) and distolic (DBP) blood pressure, heart rate (HR), blood oxygen saturation (OXYG) and body temperature (TEMP) were recorded every hour at the blood collection time points. The blood samples were transferred into heparinised tubes and they were centrifuged immediately after collection. The plasma was stored at 4°C. The propofol concentration in plasma was measured within eight weeks by high-performance liquid chromatography with a fluorescence detector \[[@CR18]\]. The limit of quantification was estimated at 0.01 mg/l. The within-day coefficients of variation and the between-day coefficients of variation were less than 10%.

Population pharmacokinetic modeling {#Sec4}
-----------------------------------

Population nonlinear mixed-effect modeling was done using NONMEM (Version 6.1.0, Icon Development Solutions, Ellicott City, MD, USA) and the Intel Fortran Compiler 9.0. NONMEM runs were executed using Wings for NONMEM (WFN611, <http://wfn.sourceforge.net>). The first-order conditional estimation with interaction (FOCE) method was used. The minimum value of the NONMEM objective function (*MOF*), typical goodness-of-fit diagnostic plots, and an evaluation of the precision of pharmacokinetic parameter and variability estimates were used to discriminate between various models during the model-building process.

PK/PD model of propofol {#Sec5}
-----------------------

The propofol concentration in the plasma versus time (t) was described by a two-compartment model (ADVAN3, TRANS4):$$\documentclass[12pt]{minimal}
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                \begin{document}$$ \begin{aligned} V_{C} {\frac{{dC_{P} }}{dt}} & = {\text{Input}} - Cl \cdot C_{P} - Cl_{D} \cdot C_{P} \,\, + Cl_{D} \cdot C_{T} \\ V_{T} {\frac{{dC_{T} }}{dt}} & = Cl_{D} \cdot C_{p} \,\, - Cl_{D} \cdot C_{T} \\ \end{aligned} $$\end{document}$$where *C*~*P*~ and *C*~*T*~ are the propofol concentrations in the central and peripheral compartment, *V*~*C*~ and *V*~*T*~ denote the volumes of the central and peripheral compartment, and *Cl* and *Cl*~*D*~ denotes the metabolic and inter-compartmental clearance. The input reflects the infusion rate and all extra boluses that were given to individual patients.

The time course of electroencephalographic (EEG) bispectral index (BIS) has been described by a direct effect model:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ BIS(t) = BIS_{0} - {\frac{{E_{\max } C_{P} }}{{EC_{50} + C_{P} }}} $$\end{document}$$where *BIS*~*0*~ denotes the baseline BIS score (fully awake). It was fixed to 100. The *E*~*max*~ is the maximal effect also fixed to 100 and *EC*~*50*~ is the concentration for 50% decrease in BIS score.

Inter-individual variability (IIV) for the PK/PD parameters was modeled assuming log normal distribution:$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ P = \theta_{P} \exp (\eta_{P} ) $$\end{document}$$where *P* is the individual parameter, *θ*~*P*~ is the typical value of this parameter in the population, and *η*~*P*~ is a random effect for that parameter with the mean 0 and variance *ω*~*P*~^*2*^. The observed concentration of propofol and BIS score were defined by the following equations:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ BIS_{obs} = BIS(1 + \varepsilon_{prop,BIS} ) $$\end{document}$$where *C*~*P*~ and BIS are defined by the Eq. [1](#Equ1){ref-type=""} and [2](#Equ2){ref-type=""} of the basic structural population model and *ε*~*prop,C*~ and *ε*~*prop,BIS*~ represents the proportional residual random errors of propofol concentrations and BIS scores. It was assumed that *ε* is normally distributed with the mean of 0 and variances denoted by *σ*~*prop,C*~^*2*^ and *σ*~*prop,BIS*~^*2*^.

Covariate search and rhythm assessment {#Sec6}
--------------------------------------

Covariate search was performed by plotting individual estimates of the PK/PD parameters against time independent covariates (body weight, age, and initial triglyceride concentration) to identify their influence. Similarly the time-dependent covariates were identified by plotting the weighted residuals of the simple model against the covariate. The time-dependent covariates were heart rate, systolic and diastolic blood pressure, body temperature and blood oxygenation. The following regression model was used:$$\documentclass[12pt]{minimal}
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The major objective of this work was to seek the presence of the circadian changes in propofol concentrations, BIS scores, and physiological parameters routinely monitored during patient stays in an ICU. For that purpose the metabolic clearance, *EC*~*50,*~ heart rate, systolic and diastolic blood pressure and body temperature were sought to be time-dependent according to the cosine function:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ P = \theta_{P} \left( {1 + \theta_{A,P} \cos \left( {{\frac{2\pi }{24}}(t - \theta_{S,P} + T)} \right)} \right)\exp (\eta_{P} ) $$\end{document}$$where *P* denotes the studied parameter (*Cl*, *EC*~*50,*~ HR, TEMP, OXYG, SBP, DBP), *θ*~*P*~ is a mesor (the average value around which the variable oscillates), *θ*~*A*,*P*~ is amplitude, *θ*~*S*,*P*~ is the acrophase (the clock time at which the peak of a rhythm occurs), and *T* is the clock time at the start of infusion. The equation assumes a 24 h fixed period and coverts time to radians.

The difference in the minimum of the NONMEM objective function (MOF) obtained for the two hierarchical models (likelihood ratio) is approximately χ^2^ distributed. During the covariate and rhythm search the effect of each covariate was examined by adding Eq. [6](#Equ6){ref-type=""} or [7](#Equ7){ref-type=""} to the base model. The likelihood ratio was determined as the difference in the objective function (MOF) of a full model (with covariate or with daily fluctuations) and reduced model (without covariate or without daily fluctuations) after refitting the data. The difference in *MOF* between models of 10.8 for one degree of freedom and of 13.8 for two degrees of freedom was considered to be statistically significant at *P* \< 0.001 for the equation to be included into the base model.

Results {#Sec7}
=======

The patient characteristics are presented in Table [1](#Tab1){ref-type="table"}. Eight male and three female patients were enrolled. The mean duration of the total propofol infusion was 98.4 ± 84.5 h. The mean duration of the propofol infusion during sample collection (second and third day of infusion) was 38.17 ± 10.98 h and the mean steady-state propofol concentration was 0.48 ± 0.21 mg/l.Table 1Demographic data and physiological parameters of subjectsParameter, unitMean ± SD (*n* = 11); rangeAge, years63 ± 11; 53--85Body weight, kg72.61 ± 22.79; 50--95Height, cm168.33 ± 8.66; 150--175Body mass index25.45 ± 7.02; 17.3--33.2Male/female8/3Duration of the infusion study period, h38.17 ± 10.98; 25--49Systolic blood pressure, mmHg135.0 ± 19.4; 85--191Diastolic blood pressure, mmHg64.6 ± 10.0; 38--98Heart rate, beats/min.89.8 ± 15.7; 60--138Body temperature, °C37.0 ± 0.5; 35.7--38.2Blood oxygen saturation, %97.4 ± 2.1; 90--100

The model building process started with a 3-compartment model according to literature findings \[[@CR19], [@CR20]\]. However, a two-compartment model was sufficient to describe our data. The propofol PK during and after prolonged infusion is presented in Fig. [1](#Fig1){ref-type="fig"}. This plot shows that the final PK model describes the measured concentrations well. The parameter estimates obtained by the fitting of the PK data are listed in Table [2](#Tab2){ref-type="table"}. The typical value of the volume of the central compartment was 27.7 l. The volume of the peripheral compartment was much higher 801 l. The metabolic clearance for typical subject equaled 2.65 l/min. It was found to depend on the systolic blood pressure according to *CL* (l/min)) = 2.65·(1 − 0.00714·(SBP − 135)). This was the only covariate found to influence the model performance with a decrease of 20.3 in MOF. The inter-compartmental clearance equaled 2.73 l/min. The selection of the IIV parameters was done according to the bottom-up approach starting from clearance, as it drives the steady-state concentration, and expanding the set parameters until failure in the estimation process was observed. The IIV of clearance equaled 48.6%. We failed to estimate IIV for any other parameters. The relative standard errors (%CV) of all estimates did not exceed 66%.Fig. 1Plot of observed (*open circle*), population predicted (*dashed line*) and individual predicted (*Solid line*) propofol concentrations versus time for the final PK model. The *shaded* area represents the dark period (8 p.m.--8 a.m). Time denotes time that has passed since the start of infusionTable 2Summary of the final population PK parameters, inter-subject and residual error variance estimates of propofolParameter, unitBasic PK modelPK model with covariateEstimate (% CV)Estimate (% CV)Fixed effect*θ*~*Cl*~, (l/min)2.55 (16)2.65 (15)·(1 − 0.00714 (66)·(SBP − 135)*θ*~*VC*~ (l)27.2 (24)27.7 (27)*θ*~*CLD*~ (l/min)2.70 (24)2.73 (28)*θ*~*VT*~*(*l)785 (35)801 (33)Inter-individual variability*ω*~*Cl*~^*2*^ (%)52.2 (50)48.6 (50)Residual variability*σ*~*prop,Cp*~^*2*^ (%)42.5 (21)41.8 (17)Performance measures*MOF*−1085.1−1105.4 (ΔMOF = −20.3)SBP denotes systolic blood pressure

The pharmacodynamic model was based on the sigmoid *E*~*max*~ model presented in the literature \[[@CR21], [@CR22]\]. The BIS score data along with model predictions are presented in Fig. [2](#Fig2){ref-type="fig"}. These plots show that the PD model described the data reasonably well. There are some parts of the data that are mis-predicted. This might be a consequence of some irregular awakening and sedation periods that were not included into the model, i.e., the daily care of patients by nurses or a short nap. The parameter estimates of the PD model are listed in Table [3](#Tab3){ref-type="table"}. The *EC*~*50*~ equaled 1.98 mg/l with IIV of 45.1%. The parameters were estimated with high precision. The relative standard error was lower than 36%. No covariates were identified for propofol PD.Fig. 2Plot of observed (*open circle*), population predicted (*dashed line*) and individual predicted (*solid line*) BIS scores versus time for the final PD model. The *shaded* area represents the dark period (8 p.m.--8 a.m). Time denotes time that has passed since the start of infusionTable 3Summary of the final population PD parameters, inter-subject and residual error variance estimates of BIS scoresParameter, unitBasic PK modelEstimate (% CV)Fixed effect*θ*~*EC50*~*,* mg/l1.98 (20%)*θ*~*EMAX*~100 (Fixed)Inter-individual variability*ω*~*EC50*~^*2*^ \[%\]45.1 (37%)Residual variability*σ*~*prop,Cp*~^*2*^ \[%\]19.1 (28%)Performance measures*MOF*2647.1

Neither for the PK or PD of propofol did we observe circadian rhythms. The inclusion of the daily fluctuations in clearance or *EC*~*50*~ did not improve the basic model performance. The MOF decreased by 4.9 for *CL* and by 13.5 for *EC*~*50*~, which was not statistically significant (*P* \< 0.001).

Significant circadian rhythms were found for the heart rate (*P* \< 0.001) and body temperature (*P* \< 0.001). The mesor, amplitude and acrophase estimates are given in Table [4](#Tab4){ref-type="table"}. The time course of body temperature and heart rate along with model predictions (Eq. [7](#Equ7){ref-type=""}) is presented in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}. The heart rate and body temperature were adequately described by the proposed model, however some mis-predictions can be observed for temperature. The average heart rate was 90.5 beats/min with moderate IIV of 14.7%. The amplitude was small and equaled 4.8% of the messor. The acrophase was 14 h reflecting an increased heart rate during the day with maximum at 02:00 p.m. The average body temperature was 37°C with low IIV of 0.82%. The amplitude was very small, 0.32% of the mesor. The acrophase was 21.4 h (21:24 p.m.). The lack of statistically significant circadian rhythms was observed with respect to SBP, DBP and blood oxygen saturation.Table 4The biological rhythms in physiological parameters with statistically significant circadian rhythms monitored in 11 ICU patients sedated with prolonged infusion of propofolPhysiological parameter (Symbol)Parameter, unitBasic modelBasic model with rhythmHeart rate (HR)*θ*~*HR*~ (beats/min)90.5 (4.7)$\documentclass[12pt]{minimal}
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Discussion {#Sec8}
==========

We assessed circadian rhythms during propofol constant infusion in critically ill patients. A three-compartment model has been widely used in studying propofol PK \[[@CR19], [@CR20]\]. However, in this work the presence of the third compartment was not justified, since it manifests itself at the first minutes after the end of infusion or bolus administration whereas our post-infusion data collection started at 3 min. The applied two-compartment model was also used for propofol PK, especially for critically ill patients \[[@CR21]--[@CR24]\]. The estimated value of metabolic clearance 2.65 l/min was in agreement with literature data obtained in ICU patients, viz. 2.11 l/min \[[@CR25]\], 1.57 l/min \[[@CR26]\], 1.50 l/min \[[@CR27]\], 1 l/min \[[@CR19]\], 2.2 l/min \[[@CR21]\] and 2.05 l/min \[[@CR22]\]. Similarly the volume of distribution at steady-state (*V*~*SS*~ = *V*~*P*~ + *V*~*T*~ = 828 l) was in agreement with literature data, namely 1699 l \[[@CR25]\], 499 l \[[@CR28]\], 1160 l \[[@CR22]\], 190 l \[[@CR21]\], 4577 l \[[@CR27]\], however V~SS~ varies considerably across studies. Our results are also comparable to the results of a multicenter population study \[[@CR19]\]. A three-compartment model gave the following parameters for a 70-kg adult: metabolic clearance 1.44 l/min, inter-compartmental clearances 2.25 and 0.92 l/min, volume of the central compartment 9.3 l and peripheral compartments 44.2 and 266 l.

In this work we identified the systolic blood pressure as a covariate affecting metabolic clearance. Propofol is highly extracted drug due to its hepatic metabolism. This results in dependence of clearance on liver blood flow. It has been shown that the rate of propofol clearance increased with the higher liver blood flow, resulting in lower propofol concentrations in blood \[[@CR24]\]. In the present study we observed that the increased SBP led to decreased clearance. However, it is difficult to draw any conclusion about the possible mechanism, since there is no direct relationship between liver blood flow and SBP, especially in critically ill patients. In the literature, in contradiction to our findings, both temperature and triglyceride concentration was found to influence the metabolic clearance \[[@CR21]\].

The utility of BIS monitoring during prolonged sedation in critically ill patients is still discussed and the literature data is mostly based on the correlation between different sedation scores \[[@CR10], [@CR12], [@CR13]\]. However, it is routinely used to monitor degree of anesthesia or sedation. Our results suggest the there is a direct link between the propofol concentrations and BIS score. The *EC*~*50*~ equaled 1.98 mg/l, which is in agreement with the *EC*~*50*~ of 2.59 mg/l for the basic model proposed by Peeters et al. \[[@CR22]\]. We did not find any statistically significant covariates. In the literature the Sequential Organ Failure Assessments (SOFA) scores was suggested as a covariate that influences the *EC*~*50*~ \[[@CR22]\]. Unfortunately, we did not collect SOFA scores to confirm these findings.

Biological rhythmicity is a fundamental regulatory principle in living organisms. All previous animal studies have shown that the maximum hypnotic effect of general anesthetics was generally obtained during the rest phase, which corresponds in humans to the night time. The longest duration of propofol anesthesia in rats occurred during the natural sleep period \[[@CR16]\]. Circadian rhythms were observed in rat hepatic enzyme activity with high values in the activity phase and low values in the rest phase \[[@CR29]\]. Since propofol is mainly metabolized by hepatic microsomal enzymes, rhythms in propofol concentrations are possible. However, our data suggest lack of daily fluctuations in the steady-state concentrations and metabolic clearance of propofol in intensive care unit patients.

Rhythmicity in propofol sedative effects might also be expected, since natural sleep and anesthesia appear to share a common mechanism \[[@CR17]\]. Nelson et al. \[[@CR17]\] noted that propofol sedation is not due to generalized inhibition throughout the CNS, but it rather involves actions on specific neuronal pathways, particularly those in the hypothalamus that underlie NREM sleep. Dispersyn et al. observed desynchronization of daily rest-activity rhythm in the days following light propofol anesthesia \[[@CR30]\]. Also, the daily variation in GABA-A activity was described in the cerebral cortex of a hamster \[[@CR31]\]. Our results did not confirm a circadian fluctuation in propofol sedation. The data obtained in animal studies cannot be extrapolated to ICU patients sedated with prolonged propofol infusion.

Albrecht et al. \[[@CR32]\] studied propofol sedative therapy with median frequency monitoring in trauma and non-trauma patients. They noted that sedation in non-trauma patients revealed some circadian patterns. In contrast the authors did not observe any fluctuations in the trauma patients group, where most of them had head injuries. Similarly, Mc Leod et al. \[[@CR33]\] observed that the rhythmicity of sedation cannot be seen in some severely ill patients. In our study patients were clinically stable during the study period and those with head injuries were excluded. In the study by Albrecht et al. propofol plasma concentrations to achieve the same level of sedation were highest between 8 a.m. and 4 p.m. and lowest between 11 p.m. and 4 a.m. This is in contradiction to our findings which showed no significant circadian rhythm with respect to BIS score during the constant infusion of propofol.

In our study we noted disturbances in the rhythmicity of the monitored physiological parameters. We recorded blood pressure, heart rate, body temperature and blood oxygen saturation every hour during the second and the third day of the propofol infusion. It is important to examine the circadian blood pressure variations because the natural rhythm alterations are known to influence life expectancy \[[@CR33]--[@CR36]\]. Both heart rate and blood pressure exhibit a strong circadian pattern with the values typically peaking in the morning. Normally, the blood pressure rises rapidly in the early morning hours due to increased plasma renin activity and increased secretion of catecholamines. In the late morning (at about 9--10 a.m.) the blood pressure reaches its peak \[[@CR34]\]. After that blood pressure declines and is the lowest between midnight and 3 a.m. In our study no BP rhytmicity was detected; suggesting severe disturbance from the natural pattern. For healthy subjects the heart rate reaches its peak around 11--12 a.m. and a nightly fall by about 10% is observed \[[@CR35], [@CR37]\]. Paul et al. \[[@CR35]\] noted a minor nocturnal fall in the ICU patients heart rate, the day--night difference equaled 3.4 beats/min (3.2% of the mean heart rate value). This is comparable to our findings.

A normal circadian pattern in the body temperature has an acrophase at about 5 p.m. with an amplitude of 0.38°C around the mean of 36.6°C. The minimum of body temperature is observed in the early morning, around 4 a.m. \[[@CR38], [@CR39]\]. The administration of sedatives is thought to suppress temperature rhythms directly by an effect on oscillators, or indirectly through an effect on consciousness \[[@CR33]\]. Paul et al. \[[@CR35]\] did not note any normal circadian pattern in body temperatures of the intensive care patients, although the authors observed a small decrease at night. The mean day value of the body temperature was 37.9 ± 1.3°C, whereas the mean night value was 37.6 ± 1.3°C. In our study, similarly to normal human variations, the patients' body temperature tended to be lower in the morning and then increased during the day. We obtained some significant day-night difference in the body temperature profile; however, a low amplitude of the mean body temperature rhythm was noted (0.12°C).

The limitation of our study was the lack of biochemical monitoring. The variations in all the monitored physiological parameters may be strongly connected with the circadian profiles of circulating melatonin, cortisol, norepinephrine, aldosterone, and other hormones. Some alterations in the concentration of these substances have been observed due to various disease states and sedative agents given \[[@CR35], [@CR36], [@CR40]\].

Conclusions {#Sec9}
===========

The light--dark cycle did not influence propofol pharmacokinetics and pharmacodynamics in intensive care unit patients. According to other monitored parameters rhythm disturbances were observed when compared to the well known rhythmic 24 h patterns. We observed circadian rhythms for heart rate and body temperature, however with very small amplitude. The lack of night--day difference was noted for both systolic and diastolic blood pressure and blood oxygen saturation. Our results support the hypothesis that endogenous rhythms in critically ill and sedated patients are severely disturbed and desynchronized.
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